20 years of CIRM: After spurring new research, CIRM’s iPSC repository closes 

In celebration of CIRM’s 20th anniversary, we have been reflecting on some of the early projects we supported and their outcomes. This blog is a little different, because it also marks the end of a project. In 2013 CIRM announced a $32 million project to create a repository of stem cell lines from people with … Continue reading 20 years of CIRM: After spurring new research, CIRM’s iPSC repository closes 

Gene Therapy for Osteoarthritis Shows Positive Results in Early Trial

Image Credit: Shutterstock Here’s a shocking statistic: in 2020, 7.6% of the world’s population was living with the most common form of arthritis – osteoarthritis (OA). That amounts to 595 million people globally and 32.5 million adults in the U.S. That’s a lot of people with painful knees, hips, and other joints. Although pain medication … Continue reading Gene Therapy for Osteoarthritis Shows Positive Results in Early Trial

20 Years of CIRM: The evolution of a CIRM-funded therapy for macular degeneration

Image Credit: University of Southern California (USC) Eye Institute In celebration of CIRM’s 20th anniversary, we are reflecting on some of the early projects we supported that have since advanced to clinical trials.  One such trial for a form of blindness originated with a 2007 SEED grant to David Hinton, MD, of the University of … Continue reading 20 Years of CIRM: The evolution of a CIRM-funded therapy for macular degeneration